1 year return (CAGR)
-92.72%
Actuate Therapeutics, Inc. Common stock Exchange (NASDAQ, USD)
ACTU
0.34
+0.05 (+11.14%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
12.68M
Price/Sales
-
Ent value
12.46M
Price/Book
12.82
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.51 |
| Daily high | 0.60 |
| Daily low | 0.48 |
| Daily Volume | 236K |
| All-time high | 11.90 |
| 1y analyst estimate | 11.68 |
| Beta | 0.96 |
| EPS (TTM) | -0.86 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 31 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ACTU | S&P500 | |
| Current price drop from All-time high | -97.18% | -3.00% |
| Highest price drop | -96.35% | -56.47% |
| Date of highest drop | 14 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -46.39% | -10.65% |
| Avg time to new high | 79 days | 12 days |
| Max time to new high | 354 days | 1805 days |
News
